Bergenstal RM, Philis-Tsimikas A, Wysham C, Carr MC, et al. Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme. Diabetes Obes Metab 2024;26:3020-3030.
PMID: 38679838